Structural Features of the Ligand-binding Domain of the Serotonin 5HT3 Receptor*
暂无分享,去创建一个
M M White | D Yan | M. Schulte | M K Schulte | K E Bloom | M. M. White | D. Yan | K. Bloom
[1] J. McNamara,et al. Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways , 1993, Neuron.
[2] R. Myers,et al. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.
[3] George G. Lunt,et al. Evolutionary history of the ligand-gated ion-channel superfamily of receptors , 1995, Trends in Neurosciences.
[4] J. Merlie,et al. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor , 1989, Neuron.
[5] J. Wells,et al. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. , 1989, Science.
[6] Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine , 1990, Neuroscience Letters.
[7] J. Garnier,et al. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. , 1978, Journal of molecular biology.
[8] D. Yan,et al. Interaction of d-tubocurarine analogs with the 5HT3 receptor , 1998, Neuropharmacology.
[9] J. A. Peters,et al. Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. , 1993, European journal of pharmacology.
[10] P. Y. Chou,et al. Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .
[11] J. B. Cohen,et al. d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[13] M. E. O'leary,et al. Mutational analysis of ligand-induced activation of the Torpedo acetylcholine receptor. , 1992, The Journal of biological chemistry.
[14] J. B. Cohen,et al. Identification of tryptophan 55 as the primary site of [3H]nicotine photoincorporation in the γ‐subunit of the Torpedo nicotinic acetylcholine receptor , 1998, FEBS letters.
[15] M. Hamon,et al. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells. , 1991, Biochemical pharmacology.
[16] A. Karlin. Structure of nicotinic acetylcholine receptors , 1993, Current Opinion in Neurobiology.
[17] Gavin Kilpatrick,et al. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells. , 1993, European journal of pharmacology.
[18] J. Changeux,et al. Functional architecture of the nicotinic acetylcholine receptor: A prototype of ligand-gated ion channels , 1993, The Journal of Membrane Biology.
[19] J. Changeux,et al. Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.
[20] I. Tsigelny,et al. A model of the nicotinic receptor extracellular domain based on sequence identity and residue location. , 1997, Biophysical journal.
[21] M. E. O'leary,et al. Characterization of d-tubocurarine binding site of Torpedo acetylcholine receptor. , 1994, The American journal of physiology.
[22] A. Karlin,et al. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins , 1995, Neuron.